Andrew Gordon Nicholson
Andrew Gordon Nicholson publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Lung Cancer Treatments and Mutations and Lung Cancer Diagnosis and Treatment.
- World rank
- #7,482 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #484 of 367,258
- Works
- 673
- Citations
- 123k
- Citations per work
- 183.4
What does Andrew Gordon Nicholson research?
Andrew Gordon Nicholson's work is mostly in Medicine (68%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences45667.8%
- Medicine45667.8%
- Everything else19028.3%
- Life Sciences263.9%
- 1Pulmonary and Respiratory Medicine45% of their works
- 2Oncology8% of their works
- 3Surgery7% of their works
- 4Molecular Biology4% of their works
- 5Pathology and Forensic Medicine4% of their works
- 6Physiology3% of their works
Research topics
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Medical Imaging and Pathology Studies
- Occupational and environmental lung diseases
- Lung Cancer Research Studies
- Pleural and Pulmonary Diseases
- Congenital Diaphragmatic Hernia Studies
Which keywords describe Andrew Gordon Nicholson's research?
The keywords of their largest research topics: Fibrosis, Idiopathic Pulmonary Fibrosis, Clinical Trials, Targeted Therapy, Chemotherapy, Immunotherapy, ALK Inhibitors and EGFR Mutations.
- Fetal Surgery
- Pleural Effusion
- Small-Cell Lung Cancer
- Malignant Pleural Mesothelioma
- Pulmonary Sclerosing Hemangioma
- Lung Cancer
- EGFR Mutations
- Immunotherapy
- Targeted Therapy
- Idiopathic Pulmonary Fibrosis
- Fibrosis
- Clinical Trials
- Chemotherapy
- ALK Inhibitors
- CT Screening
- Pulmonary Alveolar Microlithiasis
- BAP1 mutations
- Genomic Profiles
- Empyema
- Congenital Diaphragmatic Hernia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Fibrosis1801 topic
- Idiopathic Pulmonary Fibrosis1801 topic
- Clinical Trials1762 topics
- Targeted Therapy1762 topics
- Chemotherapy1712 topics
- Immunotherapy1442 topics
- ALK Inhibitors1141 topic
- EGFR Mutations1141 topic
- CT Screening1091 topic
- Lung Cancer1091 topic
- Pulmonary Alveolar Microlithiasis911 topic
- Pulmonary Sclerosing Hemangioma911 topic
- BAP1 mutations821 topic
- Malignant Pleural Mesothelioma821 topic
- Genomic Profiles621 topic
- Small-Cell Lung Cancer621 topic
- Empyema541 topic
- Pleural Effusion541 topic
- Congenital Diaphragmatic Hernia421 topic
- Fetal Surgery421 topic
Where does Andrew Gordon Nicholson work?
Andrew Gordon Nicholson's main affiliation in the publication record is Royal Brompton Hospital, United Kingdom.
How many publications and citations does Andrew Gordon Nicholson have?
OpenAlex counts 673 works and 123,441 citations for Andrew Gordon Nicholson, an h-index of 144, ranking #7,482 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Andrew Gordon Nicholson. Posts are plain text and can be reported.